Information Provided By: 
Fly News Breaks for September 23, 2019
TNDM, PODD
Sep 23, 2019 | 07:49 EDT
Insulet's (PODD) announcement this morning of an Alternate Controller Enabled designation from the FDA for OmniPod DASH is a "nice win" for the company, Piper Jaffray analyst JP McKim tells investors in a research note. Insulet is the second pump company to receive this designation as Tandem Diabetes (TNDM) has it as well, adds the analyst, who keeps an Overweight rating on Insulet shares.
News For PODD;TNDM From the Last 2 Days
